UNSPSC 51192015: Seclazone

This classification denotes a uricosuric agent with the molecular formula C10H8ClNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JW3UZ4I1A8, chemically known as 3,3a-dihydro-7-chloro-2h,9h-isoxazolo(3,2-b)(1,3)benzoxazin-9-one but generally known as seclazone, which bears US NIH Compound Identifier 34443. European Medicines Agency schedules Seclazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10466MIG.

UNSPSC 51192015 Seclazone, a Commodity code, does not align with the state and local procurement activity tagged under it. The three most recent opportunities show no purchase of seclazone — a pharmaceutical compound used in dermatology — but instead cover athletic training services, first-aid and medical aid supplies, and pharmacy benefit program consulting. The City of Tucson is soliciting comprehensive athletic training services (injury prevention, rehabilitation, return-to-duty support) for fire and police departments through an RFP due June 9, 2026; the City of Tampa's Fire Rescue Department is procuring medical aid supplies (antiseptic sprays, hydrogen peroxide, pain relievers, bandages, first aid kits, emergency blankets) through an ITB posted April 24, 2026; and the Texas Health and Human Services Commission issued a Request for Information on March 27, 2026 to explore direct-to-manufacturer pharmacy prescription programs. These solicitations reflect typical state and local government health and safety spending — occupational health support and routine medical consumables — but seclazone itself appears absent from current contracting activity.

The code shows little relevant recent activity. Procurement under this Commodity code, if it exists, is not surfacing in the posted state and local contract opportunities tracked in this period. Business development professionals evaluating this code should verify whether seclazone sees any material demand in state and local health departments, Medicaid agencies, or other issuing bodies, as the recent record suggests minimal or no purchasing volume under this specific classification.